| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/28/2004 | EP0938501B1 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
| 07/28/2004 | EP0935607B1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 07/28/2004 | EP0920509B1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0839911B1 Method for identifying attenuated varicella virus oka strain or a strain derived therefrom |
| 07/28/2004 | EP0805816B1 Compounds with growth hormone releasing properties |
| 07/28/2004 | EP0752884B1 Method of treating auto-immune diseases using type one interferons |
| 07/28/2004 | EP0728214B1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 07/28/2004 | EP0719332B1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/28/2004 | EP0584214B1 Gene manipulation and expression using genomic elements |
| 07/28/2004 | EP0452484B2 Production of proteins using homologous recombination |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516738A Acetylation of GP41 framgnets |
| 07/28/2004 | CN1516734A Transformed silkworm producing human collagen |
| 07/28/2004 | CN1516706A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 07/28/2004 | CN1516598A Antimicrobial peptides |
| 07/28/2004 | CN1516596A Method of modulating activity of calcium channels in cardiac cells and reagents therefor |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1515590A Erythropoietin conjugate |
| 07/28/2004 | CN1515589A High-effective alpha-single antiaffinity chromatographic chromatographic column for purifying recombinant human interferon |
| 07/28/2004 | CN1515588A Biological function of human testis specific gene HSD-3,8 coded protein |
| 07/28/2004 | CN1515319A Induction of cytotoxic T lymphocyte response |
| 07/28/2004 | CN1515318A Modified factor VII |
| 07/28/2004 | CN1515314A Human liver regeneration related protein and its application |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159450C Low oxygen affinity mutant hemoglobin |
| 07/28/2004 | CN1159442C Novel stranis of bacillus subtilis group for food fermentation |
| 07/28/2004 | CN1159441C USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159439C Pantropic neurotrophic factors |
| 07/28/2004 | CN1159341C Method of treatment of corticosteroid induced osteopenia |
| 07/28/2004 | CN1159340C Martentoxin as one great-conductance calcium-activating potassium channel blocker and its prepn and use |
| 07/28/2004 | CN1159339C Rice glutashion phospholipid hydrogen peroxidas gene, protein and their application |
| 07/28/2004 | CN1159333C Trichina antigen gene Ts 87 and use thereof |
| 07/28/2004 | CN1159288C Protein modifier, preparation method and use thereof |
| 07/27/2004 | US6768041 Polynucleotides that encode polypeptides involved in plant cell signaling are provided, together with genetic constructs comprising such polynucleotides |
| 07/27/2004 | US6768003 Screening a substance for the ability of the substance to modify, transcriptional activator protein function, and a method for isolating other transcriptional activator protein molecules |
| 07/27/2004 | US6768002 Scorpion toxins |
| 07/27/2004 | US6767995 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2004 | US6767994 Used in purification of apolipoprotein a (apoa) or apolipoprotein e; apoa or apoe produced by the process can be used for the manufacture of a medicament in the treatment of atherosclerosis and cardiovascular diseases |
| 07/27/2004 | US6767993 Methods and compositions for peptide synthesis |
| 07/27/2004 | US6767991 Peptides and analogs thereof; viral protease inhibitors, pharmaceutical compositions containing such peptides and ribavirin |
| 07/27/2004 | US6767897 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 07/27/2004 | US6767896 Polypeptide analgesics from snail venom |
| 07/27/2004 | US6767895 I-superfamily conotoxins |
| 07/27/2004 | US6767894 Use of ciliary neurotrophic factor |
| 07/27/2004 | US6767891 Peptides of from 28 to 44 amino acids, including therein a sequence of l-k-e-k-k, have physiological activity that can be wound healing activity, immunostimulant activity, or growth factor activity |
| 07/27/2004 | US6767889 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof |
| 07/27/2004 | US6767887 Peptides that stimulate release of insulin; treating diabetes |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767735 Introduction of a desired gene, and a plant hormone signal transduction gene as a selectable marker gene |
| 07/27/2004 | US6767722 Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 |
| 07/27/2004 | US6767721 Nucleotide sequences coding polypeptide for use in the treatment and prevention parasitic infections |
| 07/27/2004 | US6767720 Protein-protein or protein-dna interactions in a signal transduction or transcriptional pathway controlling cell growth/development in a wide range of cells; drug discovery, diagnosis and treatment of cancer and neurological disorders |
| 07/27/2004 | US6767712 Models of prion disease |
| 07/27/2004 | US6767707 DNA encoding canine von willebrand factor and methods of use |
| 07/27/2004 | US6767700 Tumor cells having tumorigenic potential but lacking invasive/metastatic potential, method for preparing them and screening method for metastasis-related genes using the same |
| 07/27/2004 | US6767566 Extraction of enyme inhibitors from plants; prepare straction solution, incubate with plant material, grind plant tissue, recover enzyme inhibitors from solution |
| 07/27/2004 | US6767545 Composition for use in treating or preventing infection by pseudomonas aeruginosa comprising a p. aeruginosa pilin protein having an n-terminal peptide region modified to prevent self assembly of the peptide |
| 07/27/2004 | US6767542 Fusing to the antigen a non-hemolytic truncated form of listeriolysin o |
| 07/27/2004 | US6767535 Suppressing tumor formation using cells expressing JE/monocyte chemoattractant protein-1 |
| 07/27/2004 | US6766613 Materials and methods for controlling pests |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/27/2004 | CA2129261C Processes of producing amylase inhibitors |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/24/2004 | CA2455701A1 The use of cross-protection to identify novel vaccine candidates for infectious agents |
| 07/24/2004 | CA2418004A1 Multiplex assays for detection and identification of viral respiratory pathogens |
| 07/22/2004 | WO2004061456A2 Uses of hmgb, hmgn, hmga proteins |
| 07/22/2004 | WO2004061423A2 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | WO2004061123A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 07/22/2004 | WO2004061122A2 Cell proliferation-related polypeptides and uses therefor |
| 07/22/2004 | WO2004061116A2 Compositions and methods for hydroxilating epothilones |
| 07/22/2004 | WO2004061113A1 Adeno-associated virus mediated b7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers |
| 07/22/2004 | WO2004061110A1 Complementation method for producing rna-containing virus-like particles of hepatotropic viruses |
| 07/22/2004 | WO2004061108A1 Adiponectin receptor and gene coding for the same |
| 07/22/2004 | WO2004061106A1 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same |
| 07/22/2004 | WO2004061105A1 Rhesus her2/neu, nucleotides encoding same, and uses thereof |
| 07/22/2004 | WO2004061103A1 Novel protein and its gene |
| 07/22/2004 | WO2004061102A1 Cell cycle-controlling protein and utilization thereof |
| 07/22/2004 | WO2004061094A1 Water-soluble thioester and selenoester compounds and methods for making and using the same |
| 07/22/2004 | WO2004061087A2 Methods and compositions of ecdysozoan molt inhibition |
| 07/22/2004 | WO2004061086A2 Flj10607 as modifier of the axin pathway and methods of use |
| 07/22/2004 | WO2004061082A2 Fanc gene mutations in cancer |
| 07/22/2004 | WO2004061080A2 Stress-related polypeptides and uses therefor |
| 07/22/2004 | WO2004061077A2 Increasing gamete production with a gene switch |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060925A2 Multiplex polymer ligation |
| 07/22/2004 | WO2004060916A2 Peptide compound containing boron |
| 07/22/2004 | WO2004060915A2 Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof. |
| 07/22/2004 | WO2004060914A1 A human liver regeneration associated protein and the use of it |
| 07/22/2004 | WO2004060910A2 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 07/22/2004 | WO2004060909A2 Increasing production of proteins in gram-positive microorganisms |
| 07/22/2004 | WO2004060867A2 Secreted protein factor and cell membrane-bound splice variant |
| 07/22/2004 | WO2004060528A1 Method for purification of alpha-1-antitrypsin |
| 07/22/2004 | WO2004060408A1 p53 TREATMENT OF PAPILLOMAVIRUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS |
| 07/22/2004 | WO2004060392A1 Lactoferrin protein with iron for treating iron deficiency and anemia |
| 07/22/2004 | WO2004060386A1 Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein |
| 07/22/2004 | WO2004060385A1 Ophthalmic therapeutic composition |